Eduard Sanchez
About Eduard Sanchez
Eduard Sanchez serves as the Vice President of Research and Development at Hamilton Thorne Inc. and has been the CEO of Microptic since 2020, specializing in biotechnology and automatic microscopic systems.
Current Role at Hamilton Thorne
Eduard Sanchez serves as the Vice President of Research and Development at Hamilton Thorne Inc. since 2022. In this role, he focuses on advancing the company's innovations in the field of reproductive health technology. His leadership is instrumental in driving research initiatives and product development strategies that align with industry standards and customer needs.
Leadership at Microptic
Since 2020, Eduard Sanchez has held the position of CEO at Microptic, located in Barcelona, Cataluña, España. Under his leadership, the company has focused on the development of automatic microscopic systems that leverage artificial intelligence, deep learning, and computer vision. His vision has contributed to enhancing the capabilities of the company's product offerings in the biotechnology sector.
Education and Expertise
Eduard Sanchez has a strong educational background in computer science and engineering. He studied at Universitat Autònoma de Barcelona, earning an engineering degree from 1995 to 2000. He furthered his education at Høgskolen i Molde, completing a final project in computer science in 2000. Additionally, he obtained an MSc from the Computer Vision Center (CVC) in 2001 and completed the PDD-2 program at IESE Business School - University of Navarra in 2017.
Specialization in Biotechnology
Eduard Sanchez specializes in biotechnology, particularly in the development of automatic microscopic systems. His work integrates artificial intelligence, deep learning, and computer vision technologies. He has significant expertise in in vitro diagnostic (IVD) medical devices and ensuring compliance with ISO13485 standards, which are critical for quality management in medical device manufacturing.
Achievements in Medical Technology
Eduard Sanchez is known for developing the Sperm Class Analyzer (SCA), a prominent Computer Aided Semen Analyzer system. This system is utilized in over 100 countries, showcasing its global impact in the field of reproductive health. His contributions to the development of this technology reflect his commitment to advancing medical diagnostics and improving patient outcomes.